Trump administration suspends South Africa from AGOA, ending duty-free access from 2027

Trump administration suspends South Africa from AGOA, ending duty-free access from 2027

How HYROX turned a fitness competition into a global business

Made in South Africa? Not when it comes to medical equipment

SARS puts social media influencers firmly on the tax radar

South Africa has been suspended from the African Growth and Opportunity Act (AGOA) – dealing a further blow to already strained relations with the United States.

The decision, announced by the Trump administration on Monday evening, will see South Africa lose its preferential duty-free access to the American market from the first of January 2027.

ALSO READ: America extends AGOA, but SA investment uncertainty remains

The move comes after months of diplomatic friction between Washington and Pretoria, with disagreements over South Africa’s land reform and black economic empowerment policies

This is coupled with false claims of persecution against white South Africans.

Tensions also escalated after South Africa took Israel to the International Court of Justice over allegations of genocide in Gaza, a case opposed by Washington.

The US capital said that South Africa’s trade barriers, corruption, and what it describes as threats to American national security and foreign policy interests are inconsistent with AGOA’s eligibility requirements.

Never miss a major story. Get breaking news and the latest developments from South Africa and beyond as they happen.

Take a look at the topic timeline for all related articles.

6 hours ago6 hours ago8 hours ago10 hours ago11 hours ago11 hours ago12 hours ago13 hours ago13 hours ago14 hours agoMore in Local2 November 2026 17:34

The day that was: Special voters make their mark, Agrizzi to pay state R1.6bn & Gauteng water crisis blamed on system failure

2 accused in Phala Phala farm theft found guilty

📰 Original Source Attribution

Reported by ewn.co.za.

Read Original Report at ewn.co.za ↗
Share: WhatsApp WhatsApp
💬

Comments (0)

Join the Conversation

No comments yet. Be the first to share your opinion!

You may like